Saturna Capital Corp’s Eli Lilly & Co Position
Does Saturna Capital Corp own Eli Lilly & Co (LLY)? Yes — 555.1K shares worth $511M (+7.16% of its 13F portfolio) as of Q1 2026, down from 561.3K shares the prior filed quarter.
Position Value
$511M
Q1 2026
Shares
555.1K
% of Portfolio
+7.16%
Quarters Held
29
currently held
Position History LLY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 555.1K | $511M | +7.16% |
| Q4 2025 | 561.3K | $603M | +8.00% |
| Q3 2025 | 589.5K | $450M | +5.80% |
| Q2 2025 | 593.6K | $463M | +6.25% |
| Q1 2025 | 600.8K | $496M | +7.43% |
| Q4 2024 | 629.1K | $486M | +6.59% |
| Q3 2024 | 649.4K | $575M | +7.52% |
| Q2 2024 | 682.9K | $618M | +8.21% |
| Q1 2024 | 692.6K | $539M | +7.44% |
| Q4 2023 | 711.3K | $415M | +6.46% |
| Q3 2023 | 760.2K | $408M | +7.22% |
| Q2 2023 | 795.7K | $373M | +6.45% |
| Q1 2023 | 796.8K | $274M | +5.30% |
| Q4 2022 | 814.9K | $298M | +6.41% |
| Q3 2022 | 815.6K | $264M | +6.43% |
| Q2 2022 | 815.6K | $264M | +6.26% |
| Q1 2022 | 920.4K | $264M | +5.31% |
| Q4 2021 | 920.3K | $245M | +4.39% |
| Q3 2021 | 920.3K | $215M | +4.33% |
| Q2 2021 | 919.8K | $211M | +4.33% |
| Q1 2021 | 919.8K | $172M | +3.83% |
| Q4 2020 | 921.1K | $136M | +3.47% |
| Q2 2020 | 921.1K | $151M | +4.24% |
| Q1 2020 | 921.1K | $128M | +4.14% |
| Q4 2019 | 981.1K | $129M | +3.49% |
| Q3 2019 | 981.1K | $110M | +3.19% |
| Q2 2019 | 981.3K | $109M | +3.19% |
| Q1 2019 | 980.5K | $127M | +3.71% |
| Q4 2018 | 985.0K | $114M | +3.84% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Saturna Capital Corp’s full portfolio or all institutional holders of LLY.